The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder
Clinical trial NCT00044187 · COMPLETED
Trial details
- NCT number
- NCT00044187
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2001-04-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.